Item 6. EXHIBITS
10K characters. Original on sec.gov ·
Item 6. EXHIBITS
| Incorporated by Reference | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Exhibit Number | Exhibit Description | Form | File No. | Date of First Filing | Exhibit Number | Provided Herewith | ||||||||||||||||||||||||||||||||||||||||||||
| 10.1* | Form of Award Agreement under the Amended and Restated 2015 Equity Incentive Plan. | 10-K | 000-51222 | February 12, 2026 | 10.18 | |||||||||||||||||||||||||||||||||||||||||||||
| 10.2* | Letter Agreement, dated February 27, 2026, between DexCom, Inc. and Kevin Sayer. | 8-K | 000-51222 | March 2, 2026 | 10.1 | |||||||||||||||||||||||||||||||||||||||||||||
| 31.1 | Certification of Chief Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a). | — | — | — | — | X | ||||||||||||||||||||||||||||||||||||||||||||
| 31.2 | Certification of Chief Financial Officer Pursuant to Securities Exchange Act Rule 13a-14(a). | — | — | — | — | X | ||||||||||||||||||||||||||||||||||||||||||||
| 32.1** | Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b). | — | — | — | — | X | ||||||||||||||||||||||||||||||||||||||||||||
| 32.2** | Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b). | — | — | — | — | X | ||||||||||||||||||||||||||||||||||||||||||||
| 101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | X | ||||||||||||||||||||||||||||||||||||||||||||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | X | ||||||||||||||||||||||||||||||||||||||||||||||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | X | ||||||||||||||||||||||||||||||||||||||||||||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | X | ||||||||||||||||||||||||||||||||||||||||||||||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | X | ||||||||||||||||||||||||||||||||||||||||||||||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | X |
| Incorporated by Reference | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Exhibit Number | Exhibit Description | Form | File No. | Date of First Filing | Exhibit Number | Provided Herewith | ||||||||||||||||||||||||||||||||||||||||||||
| 104 | Cover Page Interactive Data File - the cover page from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 is formatted in Inline XBRL | X |
| * | Represents a management contract or compensatory plan, contract or arrangement. | |||||||
| ** | This certification is not deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that Dexcom specifically incorporates it by reference. |
| SIGNATURES |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| DEXCOM, INC. (Registrant) | |||||||||||||||||
| Dated: | April 30, 2026 | By: | /s/ JACOB LEACH | ||||||||||||||
| Jacob Leach, President and Chief Executive Officer (Principal Executive Officer) | |||||||||||||||||
| Dated: | April 30, 2026 | By: | /s/ JEREME SYLVAIN | ||||||||||||||
| Jereme Sylvain, Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer) |